Tolerability and dosing experience of intravenous levetiracetam in children and infants

Epilepsy Research

Volumn 81, Issue 2-3, 2008, Pages 143-147

  Michaelides, Costas ^a   Thibert, Ronald L ^a   Shapiro, Michelle J ^a   Kinirons, Peter ^a   John, Tanya ^a   Manchharam, Dipti ^a   Thiele, Elizabeth A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Children; Dosing; Infants; Intravenous; Levetiracetam; Tolerability

Indexed keywords

ETIRACETAM;

ADOLESCENT; AGITATION; ARTICLE; ATAXIA; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; COMPLEX PARTIAL SEIZURE; DRUG INFUSION; DRUG TOLERABILITY; DRUG USE; FEMALE; HOSPITALIZATION; HUMAN; INFANT; INSTITUTIONAL CARE; IRRITABILITY; LETHARGY; LEUKOCYTE COUNT; MALE; MYOCLONUS SEIZURE; NEUTROPENIA; PEDIATRICS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; TONIC CLONIC SEIZURE; TREMOR;

ADOLESCENT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; EVALUATION STUDIES AS TOPIC; FEMALE; HUMANS; INFANT; INJECTIONS, INTRAVENOUS; MALE; PIRACETAM; RETROSPECTIVE STUDIES; SEIZURES;

EID: 53249090387     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2008.05.004     Document Type: Article

References (17)

1. Baulac M., Brodie M.J., Elger C.E., Krakow K., Stockis A., Meyvisch P., and Falter U. Levetiracetam intravenous infusion as an alternative to oral dosing in patients with partial-onset seizures. Epilepsia 48 (2007) 589-592
2. Ben-Menachem E., and Falter U. Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European levetiracetam study group. Epilepsia 41 (2000) 1276-1283
3. Cereghino J.J., Biton V., Abou-Khalil B., Dreifuss F., Gauer L.J., and Leppik I. Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial. Neurology 55 (2000) 236-242
4. Coppola G., Mangano S., Tortorella G., Pelliccia A., Fels A., Romano A., Nardello R., Habetswallner F., Licciardi F., Operto F.F., and Pascotto A. Levetiracetam during 1-year follow-up in children, adolescents, and young adults with refractory epilepsy. Epilepsy Res. 59 (2004) 35-42
5. Glauser T.A. Behavioral and psychiatric adverse events associated with antiepileptic drugs commonly used in pediatric patients. J. Child Neurol. 19 Suppl. 1 (2004) S25-S38
6. Glauser T.A., Ayala R., Elterman R.D., Mitchell W.G., Van Orman C.B., Gauer L.J., Lu Z., and N159 Study Group. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Neurology 66 (2006) 1654-1660
7. Glauser T.A., Mitchell W.G., Weinstock A., Bebin M., Chen D., Coupez R., Stockis A., and Lu Z.S. Pharmacokinetics of levetiracetam in infants and young children with epilepsy. Epilepsia 48 (2007) 1117-1122
8. Goraya J.S., Khurana D.S., Valencia I., Melvin J.J., Cruz M., Legido A., and Kothare S.V. Intravenous levetiracetam in children with epilepsy. Pediatr. Neurol. 38 3 (2008) 177-180
9. Grosso S., Franzoni E., Coppola G., Iannetti P., Verrotti A., Cordelli D.M., Marchiani V., Pascotto A., Spalice A., Acampora B., Morgese G., and Balestri P. Efficacy and safety of levetiracetam: an add-on trial in children with refractory epilepsy. Seizure 14 (2005) 248-253
10. Harden C. Safety profile of levetiracetam. Epilepsia 42 Suppl. 4 (2001) 36-39
11. Kearns G.L., Abdel-Rahman S.M., Alander S.W., Blowey D.L., Leeder J.S., and Kauffman R.E. Developmental pharmacology-drug disposition, action, and therapy in infants and children. N. Eng. J. Med. 349 12 (2003) 1157-1167
12. Kossof E.H., Bergey G.K., Freeman J.M., and Vining E.P. Levetiracetam psychosis in children with epilepsy. Epilepsia 42 (2001) 1611-1613
13. Ramael S., Daoust A., Otoul C., Toublanc N., Troenaru M., Lu Z.S., and Stockis A. Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study. Epilepsia 47 (2006) 1128-1135
14. Shorvon S.D., Lowenthal A., Janz D., Bielen E., and Loiseau P. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European levetiracetam study group. Epilepsia 41 (2000) 1179-1186
15. Sirsi D., and Safdieh J.E. The safety of levetiracetam. Expert Opin. Drug Safety 6 (2007) 241-250
16. Snoeck E., Jacqmin P., Sargentini-Maier M.L., and Stockis A. Modeling and simulation of intravenous levetiracetam pharmacokinetic profiles in children to evaluate dose adaptation rules. Epilepsy Res. 76 (2007) 140-147
17. Vigevano F. Levetiracetam in pediatrics. J. Child Neurol. 20 (2005) 87-93